Wellgistics Health, Inc.

Wellgistics Health, Inc.

WGRXยทNASDAQ

$0.72

-7.8%
HealthcareMedical - Distribution

Wellgistics Health, Inc. operates as a wholesaler and distributor of pharmaceutical products to pharmaceutical manufacturers and independent retail pharmacies in the United States. The company distributes generic and branded pharmaceuticals, as well as over-the-counter healthcare and consumer products. It also offers third-party logistics services that include warehousing, inventory management, pick and pack, and shipping to small and mid-size pharmaceutical manufacturers. It also operates DelivMeds platform that serves as a pharmaceutical hub to facilitate the transfer of prescriptions and provide backend clinical concierge services to a network of independent pharmacies; and operates a retail community specialty. The company was formerly known as Danam Health, Inc. and changed its name to Wellgistics Health, Inc. in October 2024. Wellgistics Health, Inc. was incorporated in 2022 and is based in Tampa, Florida.

At a Glance

Live Snapshot
Market Cap$50.74M
EPS-0.1100
P/E Ratio-2.24
Earnings Date11/18/2025
WGRX

Wellgistics Health, Inc. Cash Conversion Engine

WGRX ยท NASDAQ
Net Income-6.86M
Depreciation & Amortization1.11M
Stock-Based Compensation1.08M
Change in Working Capital3.34M
Others93.38K
Capital Expenditures-377.29K
Free Cash Flow-1.60M

Cash Flow Quality Analysis

FCF Conversion Rate

23.4%

Weak cash conversion. Significant portion of earnings not converting to cashโ€”review working capital trends and capital intensity.

CapEx Intensity

-18.1%

Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.

FCF Growth Trend

-358.9%

Significant FCF decline raises concerns. Urgent review needed of operational performance and capital allocation.

Working Capital Impact

+$3.34M

Working capital inflow boosted cash flow. Efficient management of receivables, inventory, and payables contributing positively.

Cash Flow Quality Insight

Deteriorating cash generation: Both declining FCF and weak conversion rate signal fundamental challenges. Investigate margin pressure, rising costs, or working capital issues.

Wellgistics Health, Inc. Cash Flow Statement

WGRX โ€ข NASDAQ

Wellgistics Health, Inc. Cash Flow StatementDec 2024Dec 2023Dec 2022
OPERATING ACTIVITIES
-6.9M
-2.9M
-5.3K
1.1M
0.0
0.0
1.1M
0.0
0.0
93.4K
0.0
0.0
3.3M
2.5M
5.3K
-1.2M
-349.1K
0.0
INVESTING ACTIVITIES
-377.3K
(0.0)
(0.0)
(931.4K)
(0.0)
(0.0)
-85K
0.0
0.0
(469.1K)
(0.0)
(0.0)
FINANCING ACTIVITIES
10K
500.0
0.0
620.7K
350K
0.0
1.2M
0.0
0.0
1.8M
350.5K
0.0
CASH FLOW SUMMARY
1M
1.4K
0.0
1.4K
0.0
0.0
1M
1.4K
0.0
-1.6M
-349.1K
0.0

SEC Filings

WGRX - Filing history and reports

No SEC filings available for WGRX